| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
21.08.2012 US 201261691625 P
29.01.2013 US 201361758097 P
06.02.2013 US 201361761279 P
14.03.2013 US 201361783796 P
27.03.2013 US 201361805797 P
16.07.2013 FR 1356994
|
| (43) |
Date of publication of application: |
|
15.06.2022 Bulletin 2022/24 |
| (60) |
Divisional application: |
|
23202532.0 |
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
18194745.8 / 3470432 |
|
13759908.0 / 2888281 |
| (73) |
Proprietors: |
|
- Sanofi Biotechnology
94250 Gentilly (FR)
- Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591-6707 (US)
|
|
| (72) |
Inventors: |
|
- ARDELEANU, Marius
Tarrytown, NY 10591-6707 (US)
- GANDHI, Namita
Tarrytown, NY 10591-6707 (US)
- GRAHAM, Neil
Tarrytown, NY 10591-6707 (US)
- KIRKESSELI, Stephane C.
Bridgewater, NJ 08807 (US)
- KUNDU, Sudeep
Bridgewater, NJ 08807 (US)
- RADIN, Allen
Tarrytown, NY 10591-6707 (US)
- ROCKLIN, Ross E.
Bridgewater, NJ 08807 (US)
- WEINSTEIN, Steven P.
Tarrytown, NY 10591-6707 (US)
- DAVIDSON HAMILTON, Jennifer
Tarrytown, NY 10591-6707 (US)
- MING, Jeffrey
Bridgewater, NJ 08807 (US)
|
| (74) |
Representative: Zwicker, Jörk |
|
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München
80686 München (DE) |
| (56) |
References cited: :
|
| |
|
|
- J. CORREN ET AL: "A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4R Antagonist,
in Patients with Asthma", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE,
vol. 181, no. 8, 15 April 2010 (2010-04-15), pages 788-796, XP055013586, ISSN: 1073-449X,
DOI: 10.1164/rccm.200909-1448OC
- JARED DARVEAUX ET AL: "Biologics in Asthma-The Next Step Toward Personalized Treatment",
THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY : AN OFFICIAL JOURNAL OF AAAAI, AMERICAN
ACADEMY OF ALLERGY ASTHMA & IMMUNOLOGY, vol. 3, no. 2, 1 March 2015 (2015-03-01),
pages 152-160, XP055535036, ISSN: 2213-2198, DOI: 10.1016/j.jaip.2014.09.014
- METERAN HOWRAMAN ET AL: "Novel monoclonal treatments in severe asthma", JOURNAL OF
ASTHMA : DEVOTED TO ASTHMA AND RELATED CONDITIONS, INFORMA HEALTHCARE, USA, vol. 54,
no. 10, 30 November 2017 (2017-11-30), pages 991-1011, XP009510079, ISSN: 1532-4303,
DOI: 10.1080/02770903.2017.1296157 [retrieved on 2017-03-16]
- DIEGO BAGNASCO ET AL: "A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies
in Severe Asthma", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY., vol. 170, no.
2, 1 January 2016 (2016-01-01), pages 122-131, XP055535051, CH ISSN: 1018-2438, DOI:
10.1159/000447692
- WENZEL SALLY ET AL: "Dupilumab in Persistent Asthma with Elevated Eosinophil Levels",
THE NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 368,
no. 26, 27 June 2013 (2013-06-27), pages 2455-2466, XP008165248, ISSN: 0028-4793,
DOI: 10.1056/NEJMOA1304048 [retrieved on 2013-05-21]
|
|
